Ignite Creation Date:
2024-05-06 @ 1:14 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03972046
Status:
WITHDRAWN
Last Update Posted:
2020-10-19
First Post:
2019-05-31
Brief Title:
Neoadjuvant Use of Talimogene Laherparepvec and BRAFMEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma
Sponsor:
Organization:
TriHealth Inc